Master's Programme in Drug Discovery and Development

Education facts

Code: FLU2M

The development of new and effective medicines is one of the most important advancements in modern history. The Master's Programme in Drug Discovery and Development provides a world-class forum for you to focus on all aspects of this multidisciplinary field, which combines biology, chemistry and pharmaceutical sciences. The programme gives you the theoretical and practical knowledge required to create new and effective medicines. As part of the programme, you meet researchers at the international forefront of the field, and there will be considerable opportunities to contribute to the development of knowledge in this exciting field. You will also have the opportunity to tailor your studies to suit your strengths, interests and career goals. The programme provides you with an excellent platform for pursuing a career in industry or beginning postgraduate studies. The language of instruction is English.

Entry requirements

_Academic requirements_ A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. Also required is: * 90 credits in chemistry, biology, pharmacy or equivalent; * 7.5 credits of pharmacology; and * 15 credits of general and organic chemistry _Language requirements_ Proficiency in English equivalent to the Swedish upper secondary course English 6. This requirement can be met either by achieving the required score on an internationally recognised test, or by previous upper secondary or university studies in some countries. Detailed instructions on how to provide evidence of your English proficiency are available at [universityadmissions.se](https://www.universityadmissions.se/en/entry-requirements/english-language-requirements/).

Education offerings

Each offering has its own dates and conditions. Closed offerings are retained as history and do not mean that a new application is open.

• Master's Programme in Drug Discovery and Development

  Uppsala University

  Start date: 31 August 2026

  End date: 4 June 2028

  Pace of study: 100 %